CELC Similar Chart Price Prediction
The price of CELC is predicted to go up -1.21%, based on the high correlation periods with ADP. The similarity of these two price pattern on the periods is 97.19%.
CELC
ADP
Down: -1.21%Similarity: 97.19%
CELC Revenue Forecast
CELC EPS Forecast
CELC Analyst's Forecast
Bradley Canino
Stifel
Strong Buy
2024-10-07
Price Target
$39 → $42
Upside
+175.05%
Stifel raised the firm's price target on Celcuity to $42 from $39 and keeps a Buy rating on the shares. The firm is updating its model to add risk-adjusted gedatolisib sales for first-line endocrine-resistant HR+ mBC and second-line mCRPC, which are phase 3 and phase 1/2 trial developments, respectively, but notes that its Buy thesis is "not anchored to these opportunities," but centered on the second-line HR+ mBC Phase 3 studies that will read out for two separate patient cohorts over the next nine months.
